Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Evasc Neurovascular Closes $7.5 Million Round Led by China Investor

publication date: Jun 15, 2017
Evasc Neurovascular of Vancouver closed a $7.5 million Series A venture round, led by Yonghua Capital of Shanghai. Evasc is developing a patented aneurysm treatment device, called eCLIPs, that Evasc believes will prove to be effective in 95% of all aneurysm cases. So far, the device has been implanted in 40 patients. The latest round, which includes participation from several of Evasc's existing investors, brings Evasc's total funding raised to date to $21 million. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital